ROCHE DISCOVERY REAGENTS (AMBIS 2232206)
ID: RFQ-NIAID-24-2232206Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

CHEMICALS (6810)

Original Source

https://sam.gov/opp/057fd8456c164b588f251cbf99d29a40/view
Timeline
    Description

    The Department of Health and Human Services, National Institutes of Health, is seeking Roche Discovery Reagents through a Combined Synopsis/Solicitation notice. These reagents are used for lab experiments and maintaining continuity of results. They are ready-to-use research reagents designed for immunohistochemistry (IHC) and in situ hybridization (ISH) with the DISCOVERY ULTRA and DISCOVERY XT instruments. The purpose of this procurement is to support the research and research training programs of the National Institute of Allergy and Infectious Diseases (NIAID) in finding causes, improved methods, and prevention of immunologic and infectious diseases. The procurement includes specific items and quantities, such as DISCOVERY OmniMap anti-Rb HRP RUO (Qty - 6) and DISCOVERY Purple Kit RUO (Qty - 15), along with shipping and handling. The place of performance is in Hamilton, Montana, United States. The procurement will be awarded based on technical capability and price. Interested vendors must submit their quotes through the NIAID e-BidBoard System by August 2, 2024, at 4:00 PM EST. For more information, contact Rita Davis at rita.davis@nih.gov.

    Files
    Title
    Posted
    Award Terms and Conditions_FAR 52.212-5 May 2024.pdf
    Lifecycle
    Title
    Type
    ROCHE DISCOVERY REAGENTS (AMBIS 2232206)
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is planning to award a Firm-Fixed price purchase order for various reagents and consumables necessary for clinical patient care testing at the NIH Clinical Center. The procurement is intended to secure proprietary products from Life Technologies Corporation, which are essential for diagnosing and monitoring hematological disorders, ensuring compliance with regulatory standards, and maintaining the integrity of laboratory operations. Interested vendors capable of providing equivalent products are invited to submit capability statements by the specified deadline, with inquiries directed to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov. The acquisition will adhere to the simplified acquisition threshold and is being conducted under FAR Subpart 13.106-1(b)(i) for sole source procurement.
    Reagent Dispenser
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking information on domestically manufactured reagent dispensers through a Sources Sought notice. The procurement aims to identify U.S.-made products that meet stringent specifications, including features such as custom plate addition, high precision peristaltic pumping, and a dispensing volume capacity ranging from 0.5 to 2500μl, among others. This initiative underscores the importance of domestic manufacturing in scientific and medical instrumentation, aligning with the Buy American Act and Executive Order 14005. Interested vendors must submit their capability statements by October 25, 2024, to Kelly Lowe at kelly.lowe@nih.gov, ensuring compliance with the outlined requirements and confidentiality stipulations.
    Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract for reagents and consumables to STEMCELL Technologies Inc. for use with the RoboSep™-S Cell Separator Systems at the NIH Clinical Center in Bethesda, Maryland. The procurement includes specific items such as the EasySep HLA Chimerism WB Myeloid Positive Selection kit, the EasySep HLA Chimerism WB CD3 Positive Selection kit, and RoboSep Filter Tip Racks, which are critical for separating cell populations in allogeneic transplant patients to assess engraftment status. Interested vendors capable of providing equivalent products may submit a capability statement by the specified deadline, with inquiries directed to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov. The acquisition falls under NAICS code 325414, and the total purchase order will not exceed the simplified acquisition threshold.
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified sources regarding the availability of assay kits for the Lumipulse G1200 instrument, which is essential for conducting assays related to Alzheimer's disease biomarkers. The procurement aims to acquire state-of-the-art assay kits for quantifying serum/plasma levels of abeta42, abeta40, and pTau 217, which will be utilized in ongoing research involving stored specimens from the Baltimore Longitudinal Study of Aging (BLSA). Interested vendors are encouraged to submit capability statements detailing their ability to meet the project requirements, including manufacturing details and company qualifications, by October 28, 2024, at 5 PM Eastern Time, to Iris Merscher at iris.merscher@nih.gov. This notice serves as a Sources Sought announcement and does not constitute a solicitation for proposals or quotes.
    SERVICE AGREEMENT FOR FACSYMPHONY A5 SPECTRAL CELL ANALYZER AND HIGH THROUGHPUT SAMPLER
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a qualified contractor to provide a service agreement for the BD FACSymphony A5 Spectral Cell Analyzer and High Throughput Sampler. The procurement includes comprehensive coverage for parts, labor, and preventative maintenance, ensuring the operational efficiency of critical laboratory equipment used in research and diagnostics. The contract will be awarded based on technical capability and price, with a performance period from December 13, 2024, to December 12, 2025. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by October 21, 2024, at 12:00 am EST, and can contact Maliaka Pinkney at maliaka.pinkney@nih.gov for further inquiries.
    cDNA-PCR Sequencing Kits for long-read sequencing.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified sources regarding the availability of cDNA-PCR sequencing kits for long-read sequencing, as part of a Sources Sought notice. The primary objective is to procure PromethION flow cells and sequencing kits that are compatible with the Oxford Nanopore PromethION device, which is essential for high-throughput sequencing in research on Alzheimer’s disease and related dementias. These consumables will facilitate the analysis of DNA and RNA samples, aiding in the identification of potential therapeutic targets and biomarkers for Alzheimer's disease. Interested companies must submit their capability statements by October 28, 2024, at 5 PM Eastern Time, to Iris Merscher at iris.merscher@nih.gov, ensuring that all submissions adhere to the specified guidelines and page limits.
    Maintenance Support for Flow Cytometry Equipment
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for maintenance support services for the BD Biosciences FACSDiscover S8 flow cytometry equipment. The contractor will be responsible for providing comprehensive maintenance, including parts, labor, and unlimited service calls, ensuring the equipment remains operational for critical biomedical research. This procurement is vital for maintaining the functionality of essential laboratory instruments, with the anticipated contract period from November 27, 2024, to November 26, 2025, and options for two additional years. Interested parties must submit their quotations by 9:00 a.m. Eastern Daylight Time on October 30, 2024, to Emily Palombo at emily.palombo@nih.gov.
    BD Biosciences BD FACSLyric™ 3L10C Lease, Consumables and Service
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking qualified contractors to provide leasing, consumables, and maintenance services for the BD FACSLyric™ 3L10C system, as part of a sources sought announcement. The procurement aims to ensure the continued operation of critical laboratory equipment used for immunology flow cytometry, which is essential for delivering over one million test results annually for patient care and research. This opportunity emphasizes the need for proprietary reagents and robust support from the manufacturer, highlighting the importance of consistent and reliable testing in a clinical research environment. Interested parties must submit their responses by 12:00 PM Eastern Standard Time on October 23, 2024, to the primary contact, Kimala Winfield, at kimala.winfield@nih.gov.
    Therakos Cellex Photopheresis System Procedural Kits for the Department of Transfusion Medicine
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a firm-fixed price contract for the procurement of five cases of Therakos Cellex USA Kits, essential for emergent Extracorporeal Photopheresis (ECP) procedures at the NIH Clinical Center in Bethesda, Maryland. These procedural kits are critical for patient care, particularly for those undergoing post-stem-cell transplant treatments, as they are the only compatible kits for the THERAKOS® CELLEX® Photopheresis System Instrument. Interested parties capable of providing similar products are encouraged to submit a capability statement by October 20, 2024, at noon EST, to Tasha Lowe at lowet2@mail.nih.gov, as the procurement will follow simplified acquisition procedures exempt from competitive requirements.